Evaluating the effect of BCG vaccination for non-specific protection from infection in senior citizens during the COVID-19 pandemic: A randomised clinical trial
In a randomised clinical trial among Danish senior citizens, BCG vaccination did not reduce the overall risk of acute infection, but BCG was associated with reduced risk in participants <75 years and participants who received COVID-19 vaccines prior to enrolment.
Authors
- Lise Gehrt (ORCID: https://orcid.org/0000-0002-6590-6263)
- Rikke Christiansen
- Peter Aaby (ORCID: https://orcid.org/0000-0001-8331-1389)
- Anne Marie Rosendahl Madsen (ORCID: https://orcid.org/0000-0002-3396-3554)
- Sebastian Nielsen (ORCID: https://orcid.org/0000-0003-3384-7489)
- Lene Annette Norberg
- Mette Bliddal (ORCID: https://orcid.org/0000-0002-7637-3730)
- Christine Stabell Benn (ORCID: https://orcid.org/0000-0001-6102-3810)
- Sören Möller (ORCID: https://orcid.org/0000-0003-0858-4269)
- Tyra Grove Krause (ORCID: https://orcid.org/0000-0001-6286-5999)
- Frederik Schaltz‐Buchholzer (ORCID: https://orcid.org/0000-0001-7643-8322)
- Lars Schellerup
Institutions
- Statens Serum Institut (DK)
- Bandim Health Project (GW)
- University of Southern Denmark (DK)
- Odense Municipality (DK)
- Odense University Hospital (DK)
Publication Details
- Journal
- Journal of Infection
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1016/j.jinf.2024.106319
- Citations
- 5
- Primary Topic
- Immune responses and vaccinations
- Type
- article
- Field-Weighted Citation Impact
- 1.20
Funders
- Odense Universitetshospital
- Danmarks Frie Forskningsfond
- Statens Serum Institut